Aug 11 (Reuters) - Tevogen Bio Holdings Inc TVGN.O:
FORECASTS $1 BILLION REVENUE IN LAUNCH YEAR FOR ONCOLOGY PIPELINE
PROJECTING CUMULATIVE 5-YEAR ESTIMATE OF BETWEEN $10 BILLION AND $14 BILLION FOR ONCOLOGY PIPELINE
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.